Targeting signal transduction in pancreatic cancer treatment (Q36804444)

16 August 2017

1 reference

title

Targeting signal transduction in pancreatic cancer treatment (English)

1 reference

16 August 2017

1 reference

Jen Jen Yeh

1

1 reference

PubMed ID

17465725

16 August 2017

Channing J Der

series ordinal

2

1 reference

PubMed ID

17465725

16 August 2017

language of work or name

English

0 references

publication date

1 May 2007

1 reference

Expert Opinion on Therapeutic Targets

16 August 2017

1 reference

16 August 2017

11

1 reference

16 August 2017

5

1 reference

16 August 2017

673-694

1 reference

Mechanisms of drug inhibition of signalling molecules

16 August 2017

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.5.673

Resected adenocarcinoma of the pancreas-616 patients: results, outcomes, and prognostic indicators

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.5.673

Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.5.673

Pancreatic cancer biology and genetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.5.673

Genetics and biology of pancreatic ductal adenocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.5.673

The epidermal growth factor receptor pathway: a model for targeted therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.5.673

Global, in vivo, and site-specific phosphorylation dynamics in signaling networks

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.5.673

Epidermal growth factor receptor targeting in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.5.673

Epidermal growth factor receptor-targeted therapy for pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.5.673

The immunohistochemical expressions of epidermal growth factors, epidermal growth factor receptors and c-erbB-2 oncoprotein in human pancreatic cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.5.673

Overexpression of HER2/neu oncogene in human pancreatic carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.5.673

Cripto, a member of the epidermal growth factor family, is over-expressed in human pancreatic cancer and chronic pancreatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.5.673

Overexpression of the epidermal growth factor receptor in human pancreatic cancer is associated with concomitant increases in the levels of epidermal growth factor and transforming growth factor alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.5.673

Molecular aspects of pancreatic cancer and future perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.5.673

ErbB-4 mRNA expression is decreased in non-metastatic pancreatic cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.5.673

TGF alpha overexpression in transgenic mice induces liver neoplasia and abnormal development of the mammary gland and pancreas

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.5.673

A murine tumor progression model for pancreatic cancer recapitulating the genetic alterations of the human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.5.673

Transforming growth factor alpha expression drives constitutive epidermal growth factor receptor pathway activation and sensitivity to gefitinib (Iressa) in human pancreatic cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.5.673

Epidermal growth factor receptor-related protein inhibits cell growth and induces apoptosis of BxPC3 pancreatic cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.5.673

Epidermal growth factor receptor-related protein inhibits cell growth and invasion in pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.5.673

Antitumor activity of epidermal growth factor receptor-related protein is mediated by inactivation of ErbB receptors and nuclear factor-kappaB in pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.5.673

Inhibition of MUC4 expression suppresses pancreatic tumor cell growth and metastasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.5.673

Mucins in cancer: protection and control of the cell surface

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.5.673

RNA interference suppression of MUC1 reduces the growth rate and metastatic phenotype of human pancreatic cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.5.673

Phase I study of the humanised anti-EGFR monoclonal antibody matuzumab (EMD 72000) combined with gemcitabine in advanced pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.5.673

A review of erlotinib and its clinical use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.5.673

GEF means go: turning on RHO GTPases with guanine nucleotide-exchange factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.5.673

21 January 2018

RHO-GTPases and cancer

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.5.673

The Ras superfamily at a glance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.5.673

Ectopic expression of VAV1 reveals an unexpected role in pancreatic cancer tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.5.673

Rational design and characterization of a Rac GTPase-specific small molecule inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.5.673

Diversity of epidermal growth factor receptor-mediated activation of downstream molecules in human lung carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.5.673

Gefitinib-sensitizing EGFR mutations in lung cancer activate anti-apoptotic pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.5.673

21 January 2018

Ras and its effectors

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.5.673

The extracellular signal-regulated kinase: multiple substrates regulate diverse cellular functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.5.673

Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.5.673

Stable suppression of tumorigenicity by virus-mediated RNA interference

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.5.673

Reduction in the requirement of oncogenic Ras signaling to activation of PI3K/AKT pathway during tumor maintenance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.5.673

Molecular consequences of silencing mutant K-ras in pancreatic cancer cells: justification for K-ras-directed therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.5.673

Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.5.673

The role of the metal ion in the p21ras catalysed GTP-hydrolysis: Mn2+ versus Mg2+

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.5.673

Lipid posttranslational modifications. Farnesyl transferase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.5.673

A phase II study of farnesyl transferase inhibitor R115777 in pancreatic cancer: a Southwest oncology group (SWOG 9924) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.5.673

Phase II and pharmacodynamic study of the farnesyltransferase inhibitor R115777 as initial therapy in patients with metastatic pancreatic adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.5.673

Phase III trial of gemcitabine plus tipifarnib compared with gemcitabine plus placebo in advanced pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.5.673

Understanding Ras: 'it ain't over 'til it's over'.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.5.673

Renewing the conspiracy theory debate: does Raf function alone to mediate Ras oncogenesis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.5.673

Targeting the mitogen-activated protein kinase cascade to treat cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.5.673

Raf: a strategic target for therapeutic development against cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.5.673

Mutations of the BRAF gene in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.5.673

BRAF and K-ras gene mutations in human pancreatic cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.5.673

Molecular analysis of the EGFR-RAS-RAF pathway in pancreatic ductal adenocarcinomas: lack of mutations in the BRAF and EGFR genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.5.673

BRAF and FBXW7 (CDC4, FBW7, AGO, SEL10) mutations in distinct subsets of pancreatic cancer: potential therapeutic targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.5.673

Activation of RalA is critical for Ras-induced tumorigenesis of human cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.5.673

Pancreatic tumor cells with mutant K-ras suppress ERK activity by MEK-dependent induction of MAP kinase phosphatase-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.5.673

Pharmacologic inhibition of RAF-->MEK-->ERK signaling elicits pancreatic cancer cell cycle arrest through induced expression of p27Kip1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.5.673

Cooperative regulation of the cell division cycle by the protein kinases RAF and AKT

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.5.673

Phase I and pharmacodynamic study of the oral MEK inhibitor CI-1040 in patients with advanced malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.5.673

Targeting the PI3K-Akt pathway in human cancer: rationale and promise

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.5.673

Divergent roles for RalA and RalB in malignant growth of human pancreatic carcinoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.5.673

The PI 3-kinase/Akt signaling pathway is activated due to aberrant Pten expression and targets transcription factors NF-kappaB and c-Myc in pancreatic cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.5.673

PIK3CA mutations in intraductal papillary mucinous neoplasm/carcinoma of the pancreas

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.5.673

High frequency of mutations of the PIK3CA gene in human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.5.673

Incidence, mechanism and prognostic value of activated AKT in pancreas cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.5.673

Dominant negative inhibitors of signalling through the phosphoinositol 3-kinase pathway for gene therapy of pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.5.673

Pten constrains centroacinar cell expansion and malignant transformation in the pancreas

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.5.673

Ral-GTPases: approaching their 15 minutes of fame

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.5.673

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.5.673

RalB GTPase-mediated activation of the IkappaB family kinase TBK1 couples innate immune signaling to tumor cell survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.5.673

PKC regulates a farnesyl-electrostatic switch on K-Ras that promotes its association with Bcl-XL on mitochondria and induces apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.5.673

The role of Notch in tumorigenesis: oncogene or tumour suppressor?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.5.673

Notch signalling: a simple pathway becomes complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.5.673

Multiple niches for Notch in cancer: context is everything

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.5.673

Notch1 functions as a tumor suppressor in mouse skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.5.673

Notch signaling controls multiple steps of pancreatic differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.5.673

Activated Notch1 prevents differentiation of pancreatic acinar cells and attenuate endocrine development

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.5.673

Notch inhibits Ptf1 function and acinar cell differentiation in developing mouse and zebrafish pancreas

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.5.673

Down-regulation of Notch-1 contributes to cell growth inhibition and apoptosis in pancreatic cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.5.673

The love-hate relationship between Ras and Notch.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.5.673

Modulation of notch signaling elicits signature tumors and inhibits hras1-induced oncogenesis in the mouse mammary epithelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.5.673

Nicastrin: gatekeeper of the gamma-secretase complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.5.673

The Notch ligands, Delta1 and Jagged2, are substrates for presenilin-dependent "gamma-secretase" cleavage

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.5.673

Role of the ErbB-4 carboxyl terminus in gamma-secretase cleavage

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.5.673

A presenilin-1/gamma-secretase cleavage releases the E-cadherin intracellular domain and regulates disassembly of adherens junctions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.5.673

Hedgehog signaling in pancreas development and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.5.673

Hedgehog signaling in the normal and diseased pancreas

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.5.673

Hedgehog signalling in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.5.673

Widespread requirement for Hedgehog ligand stimulation in growth of digestive tract tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.5.673

Hedgehog is an early and late mediator of pancreatic cancer tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.5.673

Indian hedgehog signaling pathway: expression and regulation in pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.5.673

Aberrant methylation of the Human Hedgehog interacting protein (HHIP) gene in pancreatic neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.5.673

Localization of the human hedgehog-interacting protein (Hip) in the normal and diseased pancreas

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.5.673

Hedgehog/Ras interactions regulate early stages of pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.5.673

Nuclear factor-kappaB in cancer development and progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.5.673

Mitogenic and antiapoptotic role of constitutive NF-kappaB/Rel activity in pancreatic cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.5.673

Increased expression of NF-kappa B subunits in human pancreatic cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.5.673

Inhibition of constitutive NF-kappa B activity by I kappa B alpha M suppresses tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.5.673

NF-kappaB activity blockade impairs the angiogenic potential of human pancreatic cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.5.673

The function of multiple IkappaB : NF-kappaB complexes in the resistance of cancer cells to Taxol-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.5.673

Constitutively activated nuclear factor-kappaB, but not induced NF-kappaB, leads to TRAIL resistance by up-regulation of X-linked inhibitor of apoptosis protein in human cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.5.673

Epidermal growth factor promotes invasiveness of pancreatic cancer cells through NF-kappaB-mediated proteinase productions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.5.673

Nuclear factor-kappaB contributes to hedgehog signaling pathway activation through sonic hedgehog induction in pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.5.673

Inhibition of NF-kappaB sensitizes human pancreatic carcinoma cells to apoptosis induced by etoposide (VP16) or doxorubicin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.5.673

Chemosensitivity of human pancreatic carcinoma cells is enhanced by IkappaBalpha super-repressor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.5.673

Role of NF-kappaB and Akt/PI3K in the resistance of pancreatic carcinoma cell lines against gemcitabine-induced cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.5.673

The IKK NF-kappa B system: a treasure trove for drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.5.673

Inhibitors of NF-kappaB signaling: 785 and counting

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.5.673

Inhibition of nuclear factor kappab activity by genistein is mediated via Notch-1 signaling pathway in pancreatic cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.5.673

Molecular evidence for increased antitumor activity of gemcitabine by genistein in vitro and in vivo using an orthotopic model of pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.5.673

Nuclear factor-kappaB and IkappaB kinase are constitutively active in human pancreatic cells, and their down-regulation by curcumin (diferuloylmethane) is associated with the suppression of proliferation and the induction of apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.5.673

26S proteasome inhibition induces apoptosis and limits growth of human pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.5.673

A Phase I study of bortezomib plus irinotecan in patients with advanced solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.5.673

Development of TGF-beta signalling inhibitors for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.5.673

Tumour microenvironment: TGFbeta: the molecular Jekyll and Hyde of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.5.673

DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.5.673

Transforming growth factor-beta responsiveness in DPC4/SMAD4-null cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.5.673

Smad4/DPC4-mediated tumor suppression through suppression of angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.5.673

Restoration of SMAD4 by gene therapy reverses the invasive phenotype in pancreatic adenocarcinoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.5.673

Smad4 dependency defines two classes of transforming growth factor {beta} (TGF-{beta}) target genes and distinguishes TGF-{beta}-induced epithelial-mesenchymal transition from its antiproliferative and migratory responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.5.673

Smad4 is dispensable for normal pancreas development yet critical in progression and tumor biology of pancreas cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.5.673

Aggressive pancreatic ductal adenocarcinoma in mice caused by pancreas-specific blockade of transforming growth factor-beta signaling in cooperation with active Kras expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.5.673

Inhibition of TGFbeta signaling in cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.5.673

Targeted tumor therapy with the TGF-beta 2 antisense compound AP 12009.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.5.673

Targeting endogenous transforming growth factor beta receptor signaling in SMAD4-deficient human pancreatic carcinoma cells inhibits their invasive phenotype1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.5.673

Smad-dependent and Smad-independent pathways in TGF-beta family signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.5.673

The consensus coding sequences of human breast and colorectal cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.5.673

Notch-1 down-regulation by curcumin is associated with the inhibition of cell growth and the induction of apoptosis in pancreatic cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.5.673

Ligand induced upregulation of the type II transforming growth factor (TGF-beta) receptor enhances TGF-beta responsiveness in COLO-357 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.11.5.673

Down-regulation of notch-1 inhibits invasion by inactivation of nuclear factor-kappaB, vascular endothelial growth factor, and matrix metalloproteinase-9 in pancreatic cancer cells

21 January 2018

1 reference

3 January 2024

https://opencitations.net/index/api/v1/citations/10.1158/0008-5472.CAN-05-4281

Identifiers

DOI

10.1517/14728222.11.5.673

1 reference

16 August 2017

1 reference

PubMed ID

17465725